In the present investigation we have synthesized a series of new 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl]urea and 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl]thiourea derivatives (4Ia -4IId). The newly synthesised derivatives were characterized by using the data of IR, 1 H NMR and Mass Spectral analysis. Thus synthesised and characterized targetted compounds were further screened for their antiinflammatory activity by using Carrageenan -induced paw edema rat model. Among all the newly synthesized derivatives, Compounds 4Ia-4Ic and Compounds 4IIa-4IId were reduced the inflammation very significantly (p<0.0001), thus these compounds showed promising anti-inflammatory activity and only one compound (4Id) showed moderate anti-inflammatory activity (p<0.05).
Introduction
Among all the widely used therapeutic agents Nonsteroidal anti-inflammatory drugs (NSAIDs) primarily important for the treatment of inflammation and pain in arthritis. 1,2,4-triazoles have long been known for their antiviral activity against the influenza 1 and HIV viruses [2] [3] . Triazoles were also associated with central nervous [4] [5] [6] , antimicrobial [7] [8] [9] activities . Various derivatives of 1,2,4-triazole have been reported to possess interesting biological activities such as hypoglycemic 10 anti-inflammatory [11] [12] [13] , antibacterial 14 , antifungal 15 , anticancer 16 analgesic 17 and antidepressant activities 18 . In recent years, there has been a growing interest in the pharmacology of s-triazole and o-triazole derivatives, we have synthesized and reported 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl]urea and 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl]thiourea derivatives as the targeted compounds as per the scheme-1 and evaluated for their anti-inflammatory activity. 
Scheme 1 Experimental
Melting points of all synthesized compounds were determined by open capillary tubes and are uncorrected. The IR spectra (KBr pellets) were recorded on Spectrum BX series model spectrometer for Compounds 4Ib and 4IIa. 1 H NMR spectra were recorded for compound 4Ib and 4IIa on AV 300 MHz NMR Spectrometer, using TMS as internal standard. The mass spectra were recorded on -LCQ ion Mass spectrometer. The purity of the compounds were checked by Thin Layer Chromatography (TLC) on Merck Silica gel 60 F254 pre coated sheet using Chloroform and Ethyl acetate in 1:1 v/v.
General procedure for synthesis of Benzoicacid hydrazide
19 (1) Methylbenzoate ( 0.01 mol) was dissolved in ethanol and added hydrazinehydrate (99%) (0.03 mol) and the reaction mixture was refluxed for 2 h, cooled in icebath, The obtained product was filtered, dried and recrystallised by using ethyl alcohol.
General procedure for the synthesis of arylidenehydrazide 20 (2)
Benzoicacid hydrazide (0.01mol) and appropriate aromatic aldehydes (0.015mol) in alcohol(20ml) with 2 to 3 drops of acetic acid, heated under reflux on a water bath for one hour. The solvent was removed to possible extent by distillation under reduced pressure. The product thus obtained was filtered, washed with water dried and purified by recrystallization from ethyl alcohol.
General procedure for the synthesis of 2-(4-substitutedphenyl)-5-phenyl-1,3,4-oxadiazole 20 (3) A mixture of compound (2) (0.01mol) and sodium acetate (0.02mol) were dissolved in 30 ml of glacial acetic acid with stirring. Which was added with bromine (0.7 ml in 5ml of glacial acetic acid) slowly while stirring until the colour of bromine exists. Then the reaction mixture was poured into crushed ice and collected the precipitate and washed with water, then dried. The resulting compound was purified by recrystallization from appropriate portion of DMF and water.
General procedure for the synthesis of 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl]urea (4I)
Compound (3) (0.001 mol) was dissolved in glacial acetic acid and added with semicarbazide hydrochloride(0.0015 mol) and pinch of sodium acetate . The contents of the flask were refluxed for 8 h, poured into crushed ice. The product obtained was filtered, washed with cold alcohol, dried and recrystallised from methyl alcohol.
General procedure for the synthesis of 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl]thiourea (4II)
Compound (3) (0.001 mol) was dissolved in glacial acetic acid and added with thiosemicarbazide (0.0015 mol) and pinch of sodium acetate. The contents of the flask were refluxed for 8 h, poured into crushed ice. The product obtained was filtered, washed with cold alcohol, dried and recrystallised from methyl alcohol. Adopting this procedure totally we have synthesized eight di-phenyl-1,2,4-triazole derivatives. The yields, melting points and physical data of newly synthesized compounds were summarized in Table-1.  Table 1 . Physical data of 1-(3,5-disubstituted-4H-1,2,4-triazol-4-yl)urea and 1-(3,5-disubstituted-4H-1,2,4-triazol-4-yl)thiourea derivatives (4Ia-4IId). 
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Anti inflammatory activity
Carrageenan -induced rat paw edema method 21 was employed for evaluating the anti inflammatory activity of the synthesized compounds (4Ia-4IId). Wister Albino rats of either sex weighing approx 200-300 gm, were housed in clean polypropylene cages and kept under room temperature (25±2 O C), and relative humidity 40-50% in a 12 h light-dark cycle. Food was withdrawn 12 h before and during experimental hours. In this study, the animals were divided into groups as shown in the Table-2. Acute inflammation was produced by sub plantar injection of 0.1ml of 1% suspension of Carrageenan with 2% gum acacia in normal saline, in the right hind paw of the rats. After oral administration of the test compounds, the paw volume was measured Plethysmometrically at 1, 2, 3, and 4 h intervals. Diclofenac sodium 10mg/ml of 2% gum acacia in normal saline was used as standard drug. 
Results and Discussion
The preliminary studies on anti-inflammatory activity of the new 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl]urea and 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl] thiourea derivatives (4Ia-4IId) have generated some interesting data.
Acute toxicity studies
All the new 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl]urea and 1-[3-(4-substitutedphenyl)-5-phenyl-4H-1,2,4-triazol-4-yl] thiourea derivatives (4Ia-4IId) employed in the investigation have been found to be free from toxicity as well as toxic symptoms up to a dose of 1000mg/kg (b.w). 
Anti-inflammatory activity
Conclusion
This study reports the successful synthesis of the title compounds in good yields and moderate to potent anti inflammatory activity of these derivatives containing 1,2,4-triazole moiety which is comparable with standard drug. It has been observed that the increased antiinflammatory activity is attributed to the presence of pharmacologically active substituents like urea and thiourea groups.
